Key facts
- Notable investors include Arvo Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Perimevity
- ·The full record, as it builds
Funding rounds
No funding rounds for Perimevity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Perimevity
Developer of an artificial intelligence platform designed to support healthcare and life-science applications through clinical-grade data processing. The company's platform provides speech intelligence for medical transcription, clinical text generation, and agentic frameworks with governance and traceability, enabling healthcare providers and life-science developers to improve documentation accuracy, streamline workflows, and integrate into clinical environments while maintaining compliance and auditability.
- Sector
- Healthcare
- HQ
- Centennial, CO, United States
- Website
- perimevity.com/
- Ownership
- Privately Held (backing)
Perimevity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Perimevity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Perimevity in its N-PORT filings yet. We sweep new filings monthly.